Pub Date : 2025-06-01Epub Date: 2025-05-29DOI: 10.1080/00325481.2025.2511340
Jiacheng Wu, Zhenning Liu
Soluble barium salts including barium carbonate, nitrate, acetate, and chloride are commonly used in the manufacture of ceramics, insecticides, and rodenticides. Soluble barium salts are highly toxic to humans if ingested. Acute soluble barium poisoning is an uncommon but life-threatening problem. The fatal dose of barium chloride for man has been reported to be only 0.8 to 0.9 gram. Currently, there have been no systematic studies on acute soluble barium poisoning. Based on the retrospective analysis of 55 global cases, toxicological characteristics, clinical features and management of acute soluble barium poisoning were summarized. Barium is a competitive blocker of potassium inward rectifier channels to inhibit K+ efflux, resulting in profound hypokalemia. Acute soluble barium poisoning can result in gastrointestinal effects including vomiting and diarrhea, followed by hemodynamic disturbances, cardiac arrhythmias, muscle weakness, and cardiac arrest. Respiratory failure induced by muscle paralysis is the major cause of death. Management strategies mainly include prevention of barium absorption, administration of soluble sulfates, potassium supplementation, antiarrhythmic medications, hemodialysis/CVVHDF, and cardiorespiratory support. Timely administration of decontamination and correction of hypokalemia are the two important points. This narrative review will offer crucial information for treating patients with acute soluble barium poisoning.
{"title":"Clinical features and management strategies of acute soluble barium poisoning: a review of case reports.","authors":"Jiacheng Wu, Zhenning Liu","doi":"10.1080/00325481.2025.2511340","DOIUrl":"10.1080/00325481.2025.2511340","url":null,"abstract":"<p><p>Soluble barium salts including barium carbonate, nitrate, acetate, and chloride are commonly used in the manufacture of ceramics, insecticides, and rodenticides. Soluble barium salts are highly toxic to humans if ingested. Acute soluble barium poisoning is an uncommon but life-threatening problem. The fatal dose of barium chloride for man has been reported to be only 0.8 to 0.9 gram. Currently, there have been no systematic studies on acute soluble barium poisoning. Based on the retrospective analysis of 55 global cases, toxicological characteristics, clinical features and management of acute soluble barium poisoning were summarized. Barium is a competitive blocker of potassium inward rectifier channels to inhibit K<sup>+</sup> efflux, resulting in profound hypokalemia. Acute soluble barium poisoning can result in gastrointestinal effects including vomiting and diarrhea, followed by hemodynamic disturbances, cardiac arrhythmias, muscle weakness, and cardiac arrest. Respiratory failure induced by muscle paralysis is the major cause of death. Management strategies mainly include prevention of barium absorption, administration of soluble sulfates, potassium supplementation, antiarrhythmic medications, hemodialysis/CVVHDF, and cardiorespiratory support. Timely administration of decontamination and correction of hypokalemia are the two important points. This narrative review will offer crucial information for treating patients with acute soluble barium poisoning.</p>","PeriodicalId":94176,"journal":{"name":"Postgraduate medicine","volume":" ","pages":"338-343"},"PeriodicalIF":0.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144133355","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
<p><strong>Objectives: </strong>Newborn screening and childhood immunization are among the most successful public health initiatives. Turkey has a high vaccination coverage (95-99%), but a recent decline is concerning. Vaccine hesitancy (VH) is a growing global issue, identified by the WHO as a major public health threat. Given that VH may correlate with attitudes toward other health practices, we explored whether early engagement with the health system via newborn screening influences childhood vaccine acceptance. Although these programs are implemented separately but concurrently as part of the national healthcare system in Turkey, integrating newborn screening and immunization initiatives may increase vaccine uptake through early engagement and trust building. This study aims to evaluate the relationship between newborn screening and parental vaccine hesitancy.</p><p><strong>Methods: </strong>This study was conducted at a tertiary care center in Turkey from July 2023 to April 2024. Parental VH was assessed using the PACV scale, along with questions on demographics and parental vaccination status. Participants with PACV score ≥ 50 were classified as VH+, others as VH-. Groups were compared using t-tests, Mann - Whitney U, chi-squared, or Fisher's exact tests. Multiple logistic regression was used to analyze related factors.</p><p><strong>Results: </strong>This analytic descriptive study included 481 parents (125 with children diagnosed with biotinidase deficiency or PKU via newborn screening, and 356 with healthy children aged 2-6). The mean age of respondents was 35 years, and the majority were mothers with a college education. The main sources of vaccine information were health professionals, followed by social media and family. Overall, 19.8% of parents were vaccine-hesitant, with a lower rate in the patient group (12% vs. 22.5%). VH was higher in fathers with chronic diseases (35.1% vs 18.1%, <i>p</i> = .012) and was lower in mothers received tetanus vaccine during pregnancy (16.1% vs. 30.6%, <i>p</i> = .001) or parents who received COVID-19 vaccine (mothers: 13.9% vs. 50.6%, fathers: 14.8% vs. 49.2%, both <i>p</i> < .001). VH was lower in those consulting healthcare professionals and higher in those relying on social media or non-medical sources. Diagnosis and treatment through newborn screening had an effect of 0.47 odds on VH in the overall group (95% CI = 0.24-0.92, <i>p</i> = .028).</p><p><strong>Conclusion: </strong>This study found lower vaccine hesitancy among participants in newborn screening programs and those whose parents received adult vaccinations, potentially due to increased contact with health professionals and greater health-seeking behavior. The influence of social media on vaccine hesitancy, evident in the general population, was not observed among cases, suggesting that systematic follow-up may buffer against external risk factors. Studies with matched cohorts, real-time data collection, and anonymous surveys are needed
{"title":"Newborn screening programs promote vaccine acceptance among parents in Turkey: a cross-sectional study.","authors":"İzzet Erdal, Ayça Burcu Kahraman, Yılmaz Yıldız, Siddika Songül Yalçın","doi":"10.1080/00325481.2025.2504866","DOIUrl":"10.1080/00325481.2025.2504866","url":null,"abstract":"<p><strong>Objectives: </strong>Newborn screening and childhood immunization are among the most successful public health initiatives. Turkey has a high vaccination coverage (95-99%), but a recent decline is concerning. Vaccine hesitancy (VH) is a growing global issue, identified by the WHO as a major public health threat. Given that VH may correlate with attitudes toward other health practices, we explored whether early engagement with the health system via newborn screening influences childhood vaccine acceptance. Although these programs are implemented separately but concurrently as part of the national healthcare system in Turkey, integrating newborn screening and immunization initiatives may increase vaccine uptake through early engagement and trust building. This study aims to evaluate the relationship between newborn screening and parental vaccine hesitancy.</p><p><strong>Methods: </strong>This study was conducted at a tertiary care center in Turkey from July 2023 to April 2024. Parental VH was assessed using the PACV scale, along with questions on demographics and parental vaccination status. Participants with PACV score ≥ 50 were classified as VH+, others as VH-. Groups were compared using t-tests, Mann - Whitney U, chi-squared, or Fisher's exact tests. Multiple logistic regression was used to analyze related factors.</p><p><strong>Results: </strong>This analytic descriptive study included 481 parents (125 with children diagnosed with biotinidase deficiency or PKU via newborn screening, and 356 with healthy children aged 2-6). The mean age of respondents was 35 years, and the majority were mothers with a college education. The main sources of vaccine information were health professionals, followed by social media and family. Overall, 19.8% of parents were vaccine-hesitant, with a lower rate in the patient group (12% vs. 22.5%). VH was higher in fathers with chronic diseases (35.1% vs 18.1%, <i>p</i> = .012) and was lower in mothers received tetanus vaccine during pregnancy (16.1% vs. 30.6%, <i>p</i> = .001) or parents who received COVID-19 vaccine (mothers: 13.9% vs. 50.6%, fathers: 14.8% vs. 49.2%, both <i>p</i> < .001). VH was lower in those consulting healthcare professionals and higher in those relying on social media or non-medical sources. Diagnosis and treatment through newborn screening had an effect of 0.47 odds on VH in the overall group (95% CI = 0.24-0.92, <i>p</i> = .028).</p><p><strong>Conclusion: </strong>This study found lower vaccine hesitancy among participants in newborn screening programs and those whose parents received adult vaccinations, potentially due to increased contact with health professionals and greater health-seeking behavior. The influence of social media on vaccine hesitancy, evident in the general population, was not observed among cases, suggesting that systematic follow-up may buffer against external risk factors. Studies with matched cohorts, real-time data collection, and anonymous surveys are needed","PeriodicalId":94176,"journal":{"name":"Postgraduate medicine","volume":" ","pages":"423-438"},"PeriodicalIF":0.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144046808","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-06-01Epub Date: 2025-05-28DOI: 10.1080/00325481.2025.2510894
Yang Gao, Yang Li, Ying Zhang, Hua Jiang
Background and aims: Cardiometabolic multimorbidity (CMM), defined as ≥ 2 coexisting cardiometabol ic diseases, contributes significantly to global disease burden in older adults. Treatment burden and inflammation-related residual cardiovascular risk in this population remain poorly characterized. This study aimed to quantify treatment burden in community-dwelling older adults with CMM and explore its association with inflammatory indicators.
Methods: A random sample of 170 CMM patients (age ≥60 years) from a Shanghai community completed questionnaires, such as the Treatment Burden Questionnaire (TBQ), and underwent laboratory tests. The participants were stratified according to their treatment burden and then compared in terms of demographics, lifestyle, number of cardiometabolic diseases, medication usage, and cardiometabolic and inflammatory indicators (monocyte-to-lymphocyte ratio (MLR), neutrophil-to-lymphocyte ratio (NLR), and systemic immune-inflammation index (SII)). Linear regression models and restricted cubic splines were employed to examine the associations of treatment burden with inflammatory indicators.
Results: Among participants, 37.65% (64/170) reported high treatment burden (TBQ >59). The high TBQ group exhibited poorer medication adherence (39.06% vs. 24.53%) and higher inflammatory indicators (MLR: 0.24 vs. 0.19; NLR: 1.86 vs. 1.43; SII: 352.55 vs. 276.26). No significant differences were observed in cardiometabolic indicators (except for creatinine) or medication counts. Each 10-point TBQ increase was associated with higher MLR (β = 0.01), NLR (β = 0.11), and SII (β = 18.76) in adjusted models. Non-linear associations were observed between TBQ and NLR/SII.
Conclusion: Over one-third of elderly CMM patients experience high treatment burden linked to inflammation-driven residual cardiovascular risk. Early treatment burden assessment and anti-inflammatory strategies may improve their prognosis in primary care.
{"title":"Treatment burden and its impact on residual cardiovascular risk in community-dwelling older adults with cardiometabolic multimorbidity: an exploratory cross-sectional study.","authors":"Yang Gao, Yang Li, Ying Zhang, Hua Jiang","doi":"10.1080/00325481.2025.2510894","DOIUrl":"10.1080/00325481.2025.2510894","url":null,"abstract":"<p><strong>Background and aims: </strong>Cardiometabolic multimorbidity (CMM), defined as ≥ 2 coexisting cardiometabol ic diseases, contributes significantly to global disease burden in older adults. Treatment burden and inflammation-related residual cardiovascular risk in this population remain poorly characterized. This study aimed to quantify treatment burden in community-dwelling older adults with CMM and explore its association with inflammatory indicators.</p><p><strong>Methods: </strong>A random sample of 170 CMM patients (age ≥60 years) from a Shanghai community completed questionnaires, such as the Treatment Burden Questionnaire (TBQ), and underwent laboratory tests. The participants were stratified according to their treatment burden and then compared in terms of demographics, lifestyle, number of cardiometabolic diseases, medication usage, and cardiometabolic and inflammatory indicators (monocyte-to-lymphocyte ratio (MLR), neutrophil-to-lymphocyte ratio (NLR), and systemic immune-inflammation index (SII)). Linear regression models and restricted cubic splines were employed to examine the associations of treatment burden with inflammatory indicators.</p><p><strong>Results: </strong>Among participants, 37.65% (64/170) reported high treatment burden (TBQ >59). The high TBQ group exhibited poorer medication adherence (39.06% vs. 24.53%) and higher inflammatory indicators (MLR: 0.24 vs. 0.19; NLR: 1.86 vs. 1.43; SII: 352.55 vs. 276.26). No significant differences were observed in cardiometabolic indicators (except for creatinine) or medication counts. Each 10-point TBQ increase was associated with higher MLR (β = 0.01), NLR (β = 0.11), and SII (β = 18.76) in adjusted models. Non-linear associations were observed between TBQ and NLR/SII.</p><p><strong>Conclusion: </strong>Over one-third of elderly CMM patients experience high treatment burden linked to inflammation-driven residual cardiovascular risk. Early treatment burden assessment and anti-inflammatory strategies may improve their prognosis in primary care.</p>","PeriodicalId":94176,"journal":{"name":"Postgraduate medicine","volume":" ","pages":"396-403"},"PeriodicalIF":0.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144129873","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-06-01Epub Date: 2025-05-08DOI: 10.1080/00325481.2025.2502317
Shan Li, Zhi Du, Heng Chen, Liding Zhao, Pei Zhou, Xuan Zhang, Safraz Anwar, Jialan Lv, Zhicheng Pan, Xiaogang Guo
Objective: To evaluate the relationship between relative fat mass (RFM) with prehypertension and hypertension in general population.
Methods: This investigation was a cross-sectional study that recruited 4,885 community-dwelling residents from Zhejiang Province in September 2023 to November 2023. The logistic regression and penalized spline method were applicated to determine the correlation between RFM with prehypertension and hypertension. The interaction effects and subgroups analyses were further conducted to estimate the stability of the aforesaid findings. Besides, the category-free analysis was performed to demonstrate whether the addition of the RFM levels to the traditional model could improve the risk classification of prehypertension and hypertension.
Results: The prevalence of prehypertension and hypertension were, respectively, 64.8%. Multivariable logistic regression indicated that the risk of prehypertension (hazard ratio, 1.99; 95% confidence interval, 1.63-2.44) and hypertension (3.41; 2.81-4.14), respectively, increased by 99% and 241% per standard deviation increase in RFM after adjusting for established risk factors. Taking the participants in the lowest RFM quartile as the reference, and those with the highest quartile had a significantly increased risk of prehypertension (5.26; 3.03-9.12) and hypertension (20.42; 11.84-35.22). The restricted cubic splines demonstrated aforesaid associations were linear, and interaction and subgroup analysis observed the stability of these findings. The category-free analysis suggested that the addition of RFM to the traditional model eventuated an improvement in predictive ability of prehypertension and hypertension.
Conclusions: Our results corroborated the positive association between RFM with prehypertension and hypertension. Clinically, the calculation of RFM should be emphasized in the risk assessment of hypertension and prehypertension.
{"title":"Significance of relative fat mass to estimate prevalent prehypertension and hypertension in the general population.","authors":"Shan Li, Zhi Du, Heng Chen, Liding Zhao, Pei Zhou, Xuan Zhang, Safraz Anwar, Jialan Lv, Zhicheng Pan, Xiaogang Guo","doi":"10.1080/00325481.2025.2502317","DOIUrl":"10.1080/00325481.2025.2502317","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate the relationship between relative fat mass (RFM) with prehypertension and hypertension in general population.</p><p><strong>Methods: </strong>This investigation was a cross-sectional study that recruited 4,885 community-dwelling residents from Zhejiang Province in September 2023 to November 2023. The logistic regression and penalized spline method were applicated to determine the correlation between RFM with prehypertension and hypertension. The interaction effects and subgroups analyses were further conducted to estimate the stability of the aforesaid findings. Besides, the category-free analysis was performed to demonstrate whether the addition of the RFM levels to the traditional model could improve the risk classification of prehypertension and hypertension.</p><p><strong>Results: </strong>The prevalence of prehypertension and hypertension were, respectively, 64.8%. Multivariable logistic regression indicated that the risk of prehypertension (hazard ratio, 1.99; 95% confidence interval, 1.63-2.44) and hypertension (3.41; 2.81-4.14), respectively, increased by 99% and 241% per standard deviation increase in RFM after adjusting for established risk factors. Taking the participants in the lowest RFM quartile as the reference, and those with the highest quartile had a significantly increased risk of prehypertension (5.26; 3.03-9.12) and hypertension (20.42; 11.84-35.22). The restricted cubic splines demonstrated aforesaid associations were linear, and interaction and subgroup analysis observed the stability of these findings. The category-free analysis suggested that the addition of RFM to the traditional model eventuated an improvement in predictive ability of prehypertension and hypertension.</p><p><strong>Conclusions: </strong>Our results corroborated the positive association between RFM with prehypertension and hypertension. Clinically, the calculation of RFM should be emphasized in the risk assessment of hypertension and prehypertension.</p>","PeriodicalId":94176,"journal":{"name":"Postgraduate medicine","volume":" ","pages":"408-415"},"PeriodicalIF":0.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144047636","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-06-01Epub Date: 2025-05-29DOI: 10.1080/00325481.2025.2510709
David Martín-Enguix, Juan Carlos Aguirre Rodríguez, Abraham Hidalgo Rodríguez, María Sánchez Cambronero, María Nieves Generoso Torres, María Guisasola Cárdenas, Alicia González Bravo, Carl J Lavie, Francisco J Amaro-Gahete
Objectives: This research aimed to investigate the factors contributing to mortality in patients with type 2 diabetes (T2D) to identify the primary determinants that exacerbate mortality risks in this population.
Methods: In this cohort study, 297 T2D patients from an urban Spanish population were monitored over 49 months to assess survival. The study collected sociodemographic and clinical data, including cardiovascular risk factors and initial treatments, to examine their impact on patient survival.
Results: Of the initial 291 T2D patients, 60.1% were over 65y, with a male majority (53.3%) and average T2D duration of 8.8 years. In the 4-year follow-up, 15.4% of the patients died, predominantly due to cardiovascular disease (33.3%) and cancer (31.1%). In multivariate analysis, age (Hazard Ratio [HR] 1.169, p = 0.002) and body mass index (BMI; HR 0.807, p = 0.039) were identified as potential modulators of such relationships.
Conclusion: The present study reveals that cardiovascular disease, closely followed by cancer, are the leading causes of mortality in a Spanish T2D patients' cohort over a 4-year follow-up. In addition to age - which, as expected, was clearly associated with higher mortality - BMI was inversely associated with mortality, supporting the existence of an obesity paradox in T2D.
目的:本研究旨在调查导致2型糖尿病(T2D)患者死亡的因素,以确定加剧该人群死亡风险的主要决定因素。方法:在这项队列研究中,来自西班牙城市人群的297例T2D患者被监测了49个月,以评估生存率。该研究收集了社会人口学和临床数据,包括心血管危险因素和初始治疗,以检查它们对患者生存的影响。结果:291例T2D患者中,65岁以上患者占60.1%,男性居多(53.3%),T2D平均病程8.8年。在4年的随访中,15.4%的患者死亡,主要原因是心血管疾病(33.3%)和癌症(31.1%)。多因素分析中,年龄(危险比[HR] 1.169, p = 0.002)、体重指数(BMI;HR 0.807, p = 0.039)被认为是这种关系的潜在调节因子。结论:目前的研究表明,心血管疾病,紧随其后的是癌症,是西班牙t2dm患者4年随访期间的主要死亡原因。除了年龄(正如预期的那样,年龄明显与较高的死亡率相关)之外,BMI与死亡率呈负相关,这支持了肥胖悖论在t2dm中的存在。
{"title":"All-cause mortality among primary care patients with type 2 diabetes: a prospective cohort study.","authors":"David Martín-Enguix, Juan Carlos Aguirre Rodríguez, Abraham Hidalgo Rodríguez, María Sánchez Cambronero, María Nieves Generoso Torres, María Guisasola Cárdenas, Alicia González Bravo, Carl J Lavie, Francisco J Amaro-Gahete","doi":"10.1080/00325481.2025.2510709","DOIUrl":"10.1080/00325481.2025.2510709","url":null,"abstract":"<p><strong>Objectives: </strong>This research aimed to investigate the factors contributing to mortality in patients with type 2 diabetes (T2D) to identify the primary determinants that exacerbate mortality risks in this population.</p><p><strong>Methods: </strong>In this cohort study, 297 T2D patients from an urban Spanish population were monitored over 49 months to assess survival. The study collected sociodemographic and clinical data, including cardiovascular risk factors and initial treatments, to examine their impact on patient survival.</p><p><strong>Results: </strong>Of the initial 291 T2D patients, 60.1% were over 65y, with a male majority (53.3%) and average T2D duration of 8.8 years. In the 4-year follow-up, 15.4% of the patients died, predominantly due to cardiovascular disease (33.3%) and cancer (31.1%). In multivariate analysis, age (Hazard Ratio [HR] 1.169, <i>p</i> = 0.002) and body mass index (BMI; HR 0.807, <i>p</i> = 0.039) were identified as potential modulators of such relationships.</p><p><strong>Conclusion: </strong>The present study reveals that cardiovascular disease, closely followed by cancer, are the leading causes of mortality in a Spanish T2D patients' cohort over a 4-year follow-up. In addition to age - which, as expected, was clearly associated with higher mortality - BMI was inversely associated with mortality, supporting the existence of an obesity paradox in T2D.</p>","PeriodicalId":94176,"journal":{"name":"Postgraduate medicine","volume":" ","pages":"359-367"},"PeriodicalIF":0.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144129871","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-06-01Epub Date: 2025-05-19DOI: 10.1080/00325481.2025.2506983
Ekin Yiğit Köroğlu, Berna Evranos Öğmen, Belma Tural Balsak, Mustafa Ömer Yazicioğlu, Cevdet Aydin, Oya Topaloğlu, Reyhan Ersoy, Bekir Çakir
Objective: Accurate tumor localization is necessary for the application of minimally invasive surgery, which is preferred in the treatment of primary hyperparathyroidism. Parathormone-washout (PTH-WO) is parathyroid fine-needle aspiration followed by PTH measurement in the needle washout fluid. This study aimed to determine appropriate cutoff values for the PTH-WO method.
Methods: A total of 402 PTH-WO assays from 339 patients were included in the study. The diagnostic accuracy of the test was assessed by accepting as a positive result a PTH-WO result higher than the serum PTH level [PTH-WO/serum PTH(PTH ratio)>1]. In addition, a cutoff value for the test was established by evaluating the PTH washout results obtained in comparison with postoperative histopathology. Undiluted test results were not included to obtain a clear numerical value in this evaluation. The results of parathyroid scintigraphy and fine needle aspiration biopsy (FNAB) were compared with postoperative histopathology.
Results: While 309 (76.86%) of the PTH-WO procedures were considered positive, 93 (23.13%) were considered negative if the PTH ratio was > 1. When these results were compared with the postoperative histopathology, the test's sensitivity was 92.51%, and the specificity was 100.00%. In the analysis of the remaining 292 PTH-WO samples after excluding the undiluted ones, the sensitivity and specificity of the method were 92.3% and 94.1%, respectively, with a PTH ratio > 0.99. With a cutoff value of 99.5 ng/l for PTH-WO value, 93.1% sensitivity and 94.3% specificity were obtained. The sensitivities of parathyroid scintigraphy and FNAB were 53.4% and 15.3%, respectively.
Conclusions: The PTH-WO method is safe and cheap, with high sensitivity and specificity in localizing parathyroid tumor. In cases where radiological methods cannot achieve localization with specified cutoff values, it has high diagnostic accuracy.
目的:准确的肿瘤定位是微创手术应用的必要条件,是治疗原发性甲状旁腺功能亢进的首选方法。甲状旁腺激素冲洗(PTH- wo)是甲状旁腺细针抽吸,然后在针冲洗液中测量甲状旁腺激素。本研究旨在为PTH-WO方法确定合适的截止值。方法:对339例患者进行402项PTH-WO测定。将PTH- wo结果高于血清PTH水平(PTH - wo /血清PTH(PTH比值)>1)视为阳性结果来评估该试验的诊断准确性。此外,通过评估PTH冲洗结果与术后组织病理学比较,建立了该试验的截止值。未稀释的试验结果不包括在内,以便在本评价中获得明确的数值。将甲状旁腺显像和细针穿刺活检(FNAB)结果与术后组织病理学进行比较。结果:PTH- wo检查阳性309例(76.86%),阴性93例(23.13%)。将这些结果与术后组织病理学进行比较,该试验的敏感性为92.51%,特异性为100.00%。在剔除未稀释标本后剩余292份PTH- wo标本的分析中,该方法的灵敏度和特异性分别为92.3%和94.1%,PTH比值为bb0 0.99。PTH-WO值的截止值为99.5 ng/l,灵敏度为93.1%,特异性为94.3%。甲状旁腺闪烁成像和FNAB的敏感性分别为53.4%和15.3%。结论:PTH-WO法对甲状旁腺肿瘤的定位具有较高的敏感性和特异性,安全、廉价。在某些情况下,放射学方法不能达到特定的截止值定位,它具有很高的诊断准确性。
{"title":"Unlocking the diagnostic potential of parathormone washout: a path to accurate parathyroid tumor localization.","authors":"Ekin Yiğit Köroğlu, Berna Evranos Öğmen, Belma Tural Balsak, Mustafa Ömer Yazicioğlu, Cevdet Aydin, Oya Topaloğlu, Reyhan Ersoy, Bekir Çakir","doi":"10.1080/00325481.2025.2506983","DOIUrl":"10.1080/00325481.2025.2506983","url":null,"abstract":"<p><strong>Objective: </strong>Accurate tumor localization is necessary for the application of minimally invasive surgery, which is preferred in the treatment of primary hyperparathyroidism. Parathormone-washout (PTH-WO) is parathyroid fine-needle aspiration followed by PTH measurement in the needle washout fluid. This study aimed to determine appropriate cutoff values for the PTH-WO method.</p><p><strong>Methods: </strong>A total of 402 PTH-WO assays from 339 patients were included in the study. The diagnostic accuracy of the test was assessed by accepting as a positive result a PTH-WO result higher than the serum PTH level [PTH-WO/serum PTH(PTH ratio)>1]. In addition, a cutoff value for the test was established by evaluating the PTH washout results obtained in comparison with postoperative histopathology. Undiluted test results were not included to obtain a clear numerical value in this evaluation. The results of parathyroid scintigraphy and fine needle aspiration biopsy (FNAB) were compared with postoperative histopathology.</p><p><strong>Results: </strong>While 309 (76.86%) of the PTH-WO procedures were considered positive, 93 (23.13%) were considered negative if the PTH ratio was > 1. When these results were compared with the postoperative histopathology, the test's sensitivity was 92.51%, and the specificity was 100.00%. In the analysis of the remaining 292 PTH-WO samples after excluding the undiluted ones, the sensitivity and specificity of the method were 92.3% and 94.1%, respectively, with a PTH ratio > 0.99. With a cutoff value of 99.5 ng/l for PTH-WO value, 93.1% sensitivity and 94.3% specificity were obtained. The sensitivities of parathyroid scintigraphy and FNAB were 53.4% and 15.3%, respectively.</p><p><strong>Conclusions: </strong>The PTH-WO method is safe and cheap, with high sensitivity and specificity in localizing parathyroid tumor. In cases where radiological methods cannot achieve localization with specified cutoff values, it has high diagnostic accuracy.</p>","PeriodicalId":94176,"journal":{"name":"Postgraduate medicine","volume":" ","pages":"439-446"},"PeriodicalIF":0.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144082846","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-06-01Epub Date: 2025-05-07DOI: 10.1080/00325481.2025.2502315
Song Peng Ang, Jia Ee Chia, Kwan Lee, Madhan Shanmugasundaram, Abhishek J Deshmukh, Chayakrit Krittanawong, Jose Iglesias, Debabrata Mukherjee, Carl J Lavie
Background: The impact of diabetes mellitus (DM) on outcomes of Takotsubo cardiomyopathy (TC) remains unclear, with conflicting evidence suggesting either protective or harmful effects. This study evaluates the association between DM and in-hospital outcomes in TC patients.
Methods: A retrospective analysis of the National Inpatient Sample database (2016-2019) was conducted to compare in-hospital outcomes in TC patients with and without DM. The primary outcome was in-hospital mortality, while secondary outcomes included cardiac arrest, cardiogenic shock, and acute kidney injury (AKI). Propensity-score matching (PSM) was applied to balance covariates, and multivariable logistic regression was used to evaluate DM as an independent predictor of mortality, with results reported as adjusted odds ratios (ORs) and 95% confidence intervals (CIs).
Results: Of 63,155 TC hospitalizations 13,380 (21.2%) involved patients with DM, who were older and had higher rates of comorbidities. PSM analysis revealed a higher risk of AKI in DM patients (20.13% vs. 15.91%; OR, 1.33; 95% CI, 1.16-1.54; p < 0.001), with no significant differences in mortality, cardiogenic shock, or cardiac arrest. Patients with diabetic neuropathy showed a non-significant trend toward increased AKI risk (27.04% vs. 20.44%; OR, 1.44; 95% CI, 1.00-2.09; p = 0.053). Multivariable analysis identified comorbidities like CKD, liver disease, and coagulopathy as mortality predictors, but not DM.
Conclusion: DM was associated with a higher risk of AKI but did not affect in-hospital mortality or major cardiac events in TC patients. These findings suggest that DM has a neutral impact on TC outcomes, highlighting the need for further investigation.
背景:糖尿病(DM)对Takotsubo心肌病(TC)预后的影响尚不清楚,有相互矛盾的证据表明其有保护作用或有害作用。本研究评估糖尿病与TC患者住院预后之间的关系。方法:对2016-2019年全国住院患者样本数据库进行回顾性分析,比较合并和不合并DM的TC患者的住院结局。主要结局是院内死亡率,次要结局包括心脏骤停、心源性休克和急性肾损伤(AKI)。使用倾向评分匹配(PSM)来平衡协变量,并使用多变量逻辑回归来评估DM作为死亡率的独立预测因子,结果以调整优势比(ORs)和95%置信区间(CIs)报告。结果:在63155例TC住院患者中,13380例(21.2%)涉及糖尿病患者,这些患者年龄较大,合并症发生率较高。PSM分析显示DM患者AKI的风险更高(20.13% vs. 15.91%;或者,1.33;95% ci, 1.16-1.54;p = 0.053)。多变量分析发现CKD、肝脏疾病和凝血功能障碍等合并症是死亡率的预测因素,但DM不是。结论:DM与AKI的高风险相关,但不影响TC患者的住院死亡率或主要心脏事件。这些发现表明DM对TC结果的影响是中性的,强调了进一步研究的必要性。
{"title":"Investigating the 'Diabetes Paradox' in Takotsubo Cardiomyopathy.","authors":"Song Peng Ang, Jia Ee Chia, Kwan Lee, Madhan Shanmugasundaram, Abhishek J Deshmukh, Chayakrit Krittanawong, Jose Iglesias, Debabrata Mukherjee, Carl J Lavie","doi":"10.1080/00325481.2025.2502315","DOIUrl":"10.1080/00325481.2025.2502315","url":null,"abstract":"<p><strong>Background: </strong>The impact of diabetes mellitus (DM) on outcomes of Takotsubo cardiomyopathy (TC) remains unclear, with conflicting evidence suggesting either protective or harmful effects. This study evaluates the association between DM and in-hospital outcomes in TC patients.</p><p><strong>Methods: </strong>A retrospective analysis of the National Inpatient Sample database (2016-2019) was conducted to compare in-hospital outcomes in TC patients with and without DM. The primary outcome was in-hospital mortality, while secondary outcomes included cardiac arrest, cardiogenic shock, and acute kidney injury (AKI). Propensity-score matching (PSM) was applied to balance covariates, and multivariable logistic regression was used to evaluate DM as an independent predictor of mortality, with results reported as adjusted odds ratios (ORs) and 95% confidence intervals (CIs).</p><p><strong>Results: </strong>Of 63,155 TC hospitalizations 13,380 (21.2%) involved patients with DM, who were older and had higher rates of comorbidities. PSM analysis revealed a higher risk of AKI in DM patients (20.13% vs. 15.91%; OR, 1.33; 95% CI, 1.16-1.54; <i>p</i> < 0.001), with no significant differences in mortality, cardiogenic shock, or cardiac arrest. Patients with diabetic neuropathy showed a non-significant trend toward increased AKI risk (27.04% vs. 20.44%; OR, 1.44; 95% CI, 1.00-2.09; <i>p</i> = 0.053). Multivariable analysis identified comorbidities like CKD, liver disease, and coagulopathy as mortality predictors, but not DM.</p><p><strong>Conclusion: </strong>DM was associated with a higher risk of AKI but did not affect in-hospital mortality or major cardiac events in TC patients. These findings suggest that DM has a neutral impact on TC outcomes, highlighting the need for further investigation.</p>","PeriodicalId":94176,"journal":{"name":"Postgraduate medicine","volume":" ","pages":"352-358"},"PeriodicalIF":0.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144060628","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-06-01Epub Date: 2025-05-14DOI: 10.1080/00325481.2025.2503696
Athul Rajesh, Ryan Kovacik, Beman Wasef, Kristin Lohr, Eric Kasprowicz
Acute decompensated heart failure (ADHF) is a leading cause of hospital admissions and is associated with significant increases in morbidity and mortality, as well as marked impacts on quality of life. This review aims to guide hospital medicine providers in the management of ADHF from hospital admission to safe discharge. Hospitalists commonly care for HF patients in the acute phase, and a clear understanding of HF classification and etiologies is vital for guiding the evaluation and treatment of HF decompensation. Medical management of HF is centered around guideline-directed medical therapy (GDMT), agents which have been shown in large-scale studies to improve morbidity and mortality, while diuretics are used in adjunct to alleviate symptoms and improve volume status. As patients approach discharge, a multidisciplinary approach centering on patient education, counseling, and coordination of transitional care services can help to improve outcomes and reduce readmission risk.
{"title":"A comprehensive review of inpatient heart failure management for the hospitalist.","authors":"Athul Rajesh, Ryan Kovacik, Beman Wasef, Kristin Lohr, Eric Kasprowicz","doi":"10.1080/00325481.2025.2503696","DOIUrl":"10.1080/00325481.2025.2503696","url":null,"abstract":"<p><p>Acute decompensated heart failure (ADHF) is a leading cause of hospital admissions and is associated with significant increases in morbidity and mortality, as well as marked impacts on quality of life. This review aims to guide hospital medicine providers in the management of ADHF from hospital admission to safe discharge. Hospitalists commonly care for HF patients in the acute phase, and a clear understanding of HF classification and etiologies is vital for guiding the evaluation and treatment of HF decompensation. Medical management of HF is centered around guideline-directed medical therapy (GDMT), agents which have been shown in large-scale studies to improve morbidity and mortality, while diuretics are used in adjunct to alleviate symptoms and improve volume status. As patients approach discharge, a multidisciplinary approach centering on patient education, counseling, and coordination of transitional care services can help to improve outcomes and reduce readmission risk.</p>","PeriodicalId":94176,"journal":{"name":"Postgraduate medicine","volume":" ","pages":"327-337"},"PeriodicalIF":0.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144061723","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-06-01Epub Date: 2025-05-26DOI: 10.1080/00325481.2025.2510198
Seyhan Çankaya, Hacer Alan Dikmen, Ayşenur Ataş
Objectives: The purpose of this study was to evaluate the effect of using peanut balls during labor-on-labor memory, labor satisfaction, labor length, and neonatal APGAR scores.
Methods: This randomized, controlled, single-blind trial was conducted in 140 primiparous pregnant women (peanut ball group n = 70, control group n = 70) who delivered between January 2023 and March 2024. The study was conducted in the Obstetrics Clinic of a Medical Faculty Hospital in the Central Anatolian region of Turkey. Pregnant women in the peanut ball group were instructed to perform movements with the peanut ball after cervical dilation reached 5 cm. The control group received only standard intrapartum midwifery care. Data were collected by personal information form, labor and postpartum follow-up form (APGAR score, etc.), Birth Memory and Recall Scale, and Birth Satisfaction Scales.
Results: It was determined that the birth memory and recall memories of the pregnant women in the peanut ball group were more positive and their birth satisfaction was higher than the pregnant women in the control group (p < 0.001). The 1st minute APGAR scores (8.3 ± 0.6) and 5th minute APGAR scores (9.2 ± 0.7) of the newborns of the peanut ball group were higher than the 1st minute APGAR scores (7.8 ± 0.7) and 5th minute APGAR scores (8.5 ± 0.7) of the newborns of the control group (p < 0.001). The duration of the first stage (209.3 ± 38.6) and second stage (27.4 ± 13.7) of labor in the peanut ball group was shorter than the duration of the first stage (250.3 ± 54.6) and second stage (32.3 ± 11.3) of labor in the control group (p < 0.001, p = 0.021, respectively).
Conclusion: This study found that peanut ball application positively affected women's labor memory and recall, and increased labor satisfaction. In addition, we found that peanut ball application increased neonatal APGAR scores and shortened the duration of the first and second stages of labor.
目的:本研究的目的是评估花生球对产程记忆、产程满意度、产程长度和新生儿APGAR评分的影响。方法:本研究采用随机、对照、单盲方法,选取2023年1月至2024年3月间分娩的140例初产孕妇(花生球组70例,对照组70例)为研究对象。这项研究是在土耳其中部安纳托利亚地区一所医学院医院的产科诊所进行的。花生球组孕妇在宫颈扩张达到5厘米后,指导孕妇用花生球进行运动。对照组只接受标准的产时助产护理。采用个人信息表、产程及产后随访表(APGAR评分等)、分娩记忆与回忆量表、分娩满意度量表收集数据。结果:花生球组孕妇的出生记忆和回忆记忆较对照组孕妇更积极,分娩满意度高于对照组(p p p p = 0.021)。结论:本研究发现花生球应用对产妇的劳动记忆和回忆有积极的影响,提高了产妇的劳动满意度。此外,我们发现花生球应用增加新生儿APGAR评分,缩短第一和第二产程的持续时间。临床试验注册:www.clinicaltrials.gov (NCT06387680)。
{"title":"The effect of peanut ball use on labor memory, labor satisfaction, delivery length, and neonatal APGAR score: a randomized controlled trial.","authors":"Seyhan Çankaya, Hacer Alan Dikmen, Ayşenur Ataş","doi":"10.1080/00325481.2025.2510198","DOIUrl":"10.1080/00325481.2025.2510198","url":null,"abstract":"<p><strong>Objectives: </strong>The purpose of this study was to evaluate the effect of using peanut balls during labor-on-labor memory, labor satisfaction, labor length, and neonatal APGAR scores.</p><p><strong>Methods: </strong>This randomized, controlled, single-blind trial was conducted in 140 primiparous pregnant women (peanut ball group <i>n</i> = 70, control group <i>n</i> = 70) who delivered between January 2023 and March 2024. The study was conducted in the Obstetrics Clinic of a Medical Faculty Hospital in the Central Anatolian region of Turkey. Pregnant women in the peanut ball group were instructed to perform movements with the peanut ball after cervical dilation reached 5 cm. The control group received only standard intrapartum midwifery care. Data were collected by personal information form, labor and postpartum follow-up form (APGAR score, etc.), Birth Memory and Recall Scale, and Birth Satisfaction Scales.</p><p><strong>Results: </strong>It was determined that the birth memory and recall memories of the pregnant women in the peanut ball group were more positive and their birth satisfaction was higher than the pregnant women in the control group (<i>p</i> < 0.001). The 1st minute APGAR scores (8.3 ± 0.6) and 5th minute APGAR scores (9.2 ± 0.7) of the newborns of the peanut ball group were higher than the 1st minute APGAR scores (7.8 ± 0.7) and 5th minute APGAR scores (8.5 ± 0.7) of the newborns of the control group (<i>p</i> < 0.001). The duration of the first stage (209.3 ± 38.6) and second stage (27.4 ± 13.7) of labor in the peanut ball group was shorter than the duration of the first stage (250.3 ± 54.6) and second stage (32.3 ± 11.3) of labor in the control group (<i>p</i> < 0.001, <i>p</i> = 0.021, respectively).</p><p><strong>Conclusion: </strong>This study found that peanut ball application positively affected women's labor memory and recall, and increased labor satisfaction. In addition, we found that peanut ball application increased neonatal APGAR scores and shortened the duration of the first and second stages of labor.</p><p><strong>Clinical trial registration: </strong>www.clinicaltrials.gov (NCT06387680).</p>","PeriodicalId":94176,"journal":{"name":"Postgraduate medicine","volume":" ","pages":"368-378"},"PeriodicalIF":2.8,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144113151","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-04-21Epub Date: 2025-04-01DOI: 10.1080/00325481.2025.2476828
{"title":"Abstracts from the 19th Annual Cardiometabolic Health Congress.","authors":"","doi":"10.1080/00325481.2025.2476828","DOIUrl":"10.1080/00325481.2025.2476828","url":null,"abstract":"","PeriodicalId":94176,"journal":{"name":"Postgraduate medicine","volume":" ","pages":"1"},"PeriodicalIF":0.0,"publicationDate":"2025-04-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143756970","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}